A Year In Review
The Microbiome space has seen continued growth with over 1,000 assets now tracked in the beacon database, highlighting continued investment in this emerging field.
The Beacon Microbiome 2024 Landscape Review provides unparalleled insights into the years developments allowing you to be at the forefront of information in the space.
Download Now
Don’t miss out on the latest breakthroughs in Microbiome development!
Dive into the most comprehensive data and insights in the Microbiome space in. Discover the expanding drug pipeline, with over 1,000 assets in development, and gain a deeper understanding of preclinical dominance, clinical trial growth, and investment trends shaping the field. Stay ahead with key insights into live biotherapeutic products, bacteriophage therapies, and the latest regulatory and funding dynamics.
Report Contents
The Drug Landscape
A deep dive into the Microbiome assets added to Beacon in 2024, highlighting development phases and key therapeutic targets.
The Trial Landscape
Analysis of new Microbiome trials, including status, success rates, and trial discontinuation insights.
The Commercial Landscape
A review of Microbiome deals in 2024, analyzing investment value, partnerships, and collaboration.
The Future of The Microbiome Landscape
Emerging trends in Microbiome drug development, from therapuetic class comparisons to novel approaches.
Regulatory Announcements
Breakdown of Regulatory Updates in the Microbiome landscape
You May Also Be Interested In...
DDR: 2024 Landscape Review
Microbiome: 2024 Landscape Review
TPD: 2024 Landscape Review
Strategic Insights for Biopharma Innovation Report
H1 2024 Oncolytic Viruses Landscape Review
H1 2024 Cancer Vaccine Landscape Review
Find Out More
Beacon is the essential decision-support tool for developers of complex therapeutics. Our market-defining, proprietary ontologies combined with the most accurate and comprehensive life sciences data, provide our customers with unparalleled visibility of the drug, trial and commercial landscape. Each dataset features proprietary, hyper-relevant search and filtering tailored to specific modalities, in-depth data, plus additional market insight curated by our subject matter experts.
With Beacon, you can make drug development decisions with confidence. This is why 23 out of the world’s top 25 drug developers trust us.
Any questions? Get in touch
Our dedicated account and research teams can help you with questions by showing you how this insight and data is collated on Beacon.
